Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines

被引:11
作者
Bennett, Cade [1 ]
Suguitan, Mike [1 ]
Abad, John [1 ]
Chawla, Akhil [1 ,2 ,3 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Surg, Northwestern Med Reg Med Grp,Div Surg Oncol, Chicago, IL USA
[2] Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[3] Div Surg Oncol, Dept Surg, Northwestern Med Reg Med Grp, 4405 Weaver Pkwy, Warren, IL 60555 USA
关键词
PEUTZ-JEGHERS SYNDROME; CFTR GENE-MUTATIONS; HEREDITARY PANCREATITIS; PREDISPOSITION GENES; RELATIVE FREQUENCY; BRCA2; MUTATIONS; FANCONI-ANEMIA; SPINK1; GENE; PREVALENCE; FAMILIES;
D O I
10.1016/j.pan.2022.05.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pancreatic cancer (PC) is a product of a variety of environmental and genetic factors. Recent work has highlighted the influence of hereditary syndromes on pancreatic cancer incidence. The purpose of this review is to identify the high-risk syndromes, common variants, and risks associated with PC. The study also elucidates common characteristics of patients with these mutations, which is used to recommend potential changes to current screening protocols for greater screening efficacy. We analyzed 8 syndromes and their respective variants: Hereditary Breast and Ovarian Cancer (BRCA1/2), Familial Atypical Multiple Mole Melanoma Syndrome (CDKN2A), Peutz-Jeghers Syndrome (STK11), Lynch Syndrome (PMS2, MLH1, MSH2, MSH6, EPCAM), Ataxia Telangiectasia (ATM), Li-Fraumeni Syndrome (TP53), Fanconi Anemia (PALB2), and Hereditary Pancreatitis (PRSS1, SPINK1, CFTR). Of 587 studies evaluated, 79 studies fit into our inclusion criteria. Information from each study was analyzed to draw conclusions on these variants as well as their association with pancreatic cancer. Information from this review is intended to improve precision medicine and improve criteria for screening. (C) 2022 IAP and EPC. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:719 / 729
页数:11
相关论文
共 99 条
[21]   The prevalence of BRCA2 mutations in familial pancreatic cancer [J].
Couch, Fergus J. ;
Johnson, Michele R. ;
Rabe, Kari G. ;
Brune, Kieran ;
de Andrade, Mariza ;
Goggins, Michael ;
Rothenmund, Heidi ;
Gallinger, Steven ;
Klein, Alison ;
Petersen, Gloria M. ;
Hruban, Ralph H. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (02) :342-346
[22]   Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening [J].
Cremin, Carol ;
Lee, Michael Kuan-Ching ;
Hong, Quan ;
Hoeschen, Carolyn ;
Mackenzie, Anna ;
Dixon, Katherine ;
McCullum, Mary ;
Nuk, Jennifer ;
Kalloger, Steve ;
Karasinska, Joanna ;
Scudamore, Charles ;
Kim, Peter T. W. ;
Donnellan, Fergal ;
Lam, Eric C. S. ;
Lim, Howard J. ;
Neben, Cynthia L. ;
Stedden, Will ;
Zhou, Alicia Y. ;
Schaeffer, David F. ;
Sun, Sophie ;
Renouf, Daniel J. ;
Schrader, Kasmintan A. .
CANCER MEDICINE, 2020, 9 (11) :4004-4013
[23]   Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021 [J].
Daly, Mary B. ;
Pal, Tuya ;
Berry, Michael P. ;
Buys, Saundra S. ;
Dickson, Patricia ;
Domchek, Susan M. ;
Elkhanany, Ahmed ;
Friedman, Susan ;
Goggins, Michael ;
Hutton, Mollie L. ;
Karlan, Beth Y. ;
Khan, Seema ;
Klein, Catherine ;
Kohlmann, Wendy ;
Kurian, Allison W. ;
Laronga, Christine ;
Litton, Jennifer K. ;
Mak, Julie S. ;
Menendez, Carolyn S. ;
Merajver, Sofia D. ;
Norquist, Barbara S. ;
Offit, Kenneth ;
Pederson, Holly J. ;
Reiser, Gwen ;
Senter-Jamieson, Leigha ;
Shannon, Kristen Mahoney ;
Shatsky, Rebecca ;
Visvanathan, Kala ;
Weitzel, Jeffrey N. ;
Wick, Myra J. ;
Wisinski, Kari B. ;
Yurgelun, Matthew B. ;
Darlow, Susan D. ;
Dwyer, Mary A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (01) :77-102
[24]   Pancreatic cancer screening in high-risk individuals with germline genetic mutations [J].
Davee, Tomas ;
Coronel, Emmanuel ;
Papafragkakis, Charilaos ;
Thaiudom, Sayam ;
Lanke, Gandhi ;
Chakinala, Raja C. ;
Gonzalez, Graciela M. Nogueras ;
Bhutani, Manoop S. ;
Ross, William A. ;
Weston, Brian R. ;
Lee, Jeffrey H. .
GASTROINTESTINAL ENDOSCOPY, 2018, 87 (06) :1443-1450
[25]   Germline Mutation Prevalence in Individuals with Pancreatic Cancer and a History of Previous Malignancy [J].
Dudley, Beth ;
Karloski, Eve ;
Monzon, Federico A. ;
Singhi, Aatur D. ;
Lincoln, Stephen E. ;
Bahary, Nathan ;
Brand, Randall E. .
CANCER, 2018, 124 (08) :1691-1700
[26]   A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants [J].
Earl, Julie ;
Galindo-Pumarino, Cristina ;
Encinas, Jessica ;
Barreto, Emma ;
Castillo, Maria E. ;
Pachon, Vanessa ;
Ferreiro, Reyes ;
Rodriguez-Garrote, Mercedes ;
Gonzalez-Martinez, Silvia ;
Ramon y Cajal, Teresa ;
Robles Diaz, Luis ;
Chirivella-Gonzalez, Isabel ;
Rodriguez, Montse ;
Martinez de Castro, Eva ;
Garcia-Seisdedos, David ;
Munoz, Gloria ;
Rosa Rosa, Juan Manuel ;
Marquez, Mirari ;
Malats, Nuria ;
Carrato, Alfredo .
EBIOMEDICINE, 2020, 53
[27]   BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma [J].
Ferrone, Cristina R. ;
Levine, Douglas A. ;
Tang, Laura H. ;
Allen, Peter J. ;
Jarnagin, William ;
Brennan, Murray F. ;
Offit, Kenneth ;
Robson, Mark E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (03) :433-438
[28]   Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome [J].
Gargiulo, S. ;
Torrini, M. ;
Ollila, S. ;
Nasti, S. ;
Pastorino, L. ;
Cusano, R. ;
Bonelli, L. ;
Battistuzzi, L. ;
Mastracci, L. ;
Bruno, W. ;
Savarino, V. ;
Sciallero, S. ;
Borgonovo, G. ;
Nystroem, M. ;
Bianchi-Scarra, G. ;
Mareni, C. ;
Ghiorzo, P. .
FAMILIAL CANCER, 2009, 8 (04) :547-553
[29]   PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma [J].
Ge, Ouyang ;
Huang, Anle ;
Wang, Xin ;
Chen, Yuling ;
Ye, Yuanchun ;
Schomburg, Lutz .
ONCOLOGY LETTERS, 2021, 21 (03)
[30]   Germline genetic variability in pancreatic cancer risk and prognosis [J].
Gentiluomo, Manuel ;
Canzian, Federico ;
Nicolini, Andrea ;
Gemignani, Federica ;
Landi, Stefano ;
Campa, Daniele .
SEMINARS IN CANCER BIOLOGY, 2022, 79 :105-131